Skip to main content

Novonesis expands global footprint with acquisition of production facility in Southeast Asia

Novonesis expands global footprint with acquisition of production facility in Southeast Asia
 
Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth ambitions.

COPENHAGEN, Denmark – April 8, 2026. Novonesis has signed an agreement with Meihua to acquire a production facility in Rayong, Thailand for around USD 50 million, increasing the company’s footprint in Southeast Asia and strengthening its ability to serve customers worldwide.

Expanding in Asia is core to Novonesis’ GROW strategy towards 2030. Emerging markets already account for one third of the company’s sales and are expected to grow faster than developed markets. By investing in geographically well-positioned facilities, the company strengthens its capabilities to supply both local and global markets with its unique global multipurpose production setup.

Novonesis is acquiring a facility with advanced fermentation capabilities that can be further expanded to support the company’s growth journey, including the production of HMO (human milk oligosaccharides). Novonesis plans to invest further in the facility over the coming years to maximize its potential and establish a strong operational setup. The company expects the site to be commercially operational in 2027.

Anders Lund, Chief Operating Officer: 

“Strengthening our production footprint in Southeast Asia is an important step for Novonesis. A key part of our GROW strategy is to continue to strengthen our resilient and responsive supply network to support our long-term growth ambitions. By expanding our world-class production capabilities, we can move closer to customers in a fast-growing region and deliver even greater value to them.”
 

Novonesis investing in capacity and resilience across markets

The Rayong acquisition is one of several investments Novonesis has made in recent years to strengthen its resilience and global production setup – enabling the company to serve local customers more effectively and drive growth. Facilities in Franklinton, North Carolina, Taicang, China, Araucaria, Brazil, and West Allis, Wisconsin, have been expanded as part of this effort.

Over the current strategy period towards 2030, Novonesis expects to increase its growth-focused capital expenditure and cater for the increasing demand for biosolutions among customers and consumers.

Get in touch

Line Emilie Fedders
Senior Media Relations Manager
media-relations@novonesis.com+45 30 77 13 99

Tobias Bjorklund
Head of Investor Relations
tobb@novonesis.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.